Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs in Rheumatoid Arthritis: Results from the 2-Year Longitudinal Prospective Non-interventional STRATEGE2 Study

Abstract Introduction The primary objective was to describe the therapeutic approach to methotrexate (MTX) use at the initiation of the first biologic or targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) in the treatment of rheumatoid arthritis (RA). Secondary objectives included c...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Cécile Gaujoux-Viala, Emmanuelle Dernis, Eric Senbel, Hélène Herman-Demars, Jennifer Becker, René-Marc Flipo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Adis, Springer Healthcare 2025-12-01
Edice:	Rheumatology and Therapy
Témata:	DMARDs Methotrexate Rheumatoid arthritis Treat-to-target
On-line přístup:	https://doi.org/10.1007/s40744-025-00806-1
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!